Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Takeda Pharmaceutical CO Ltd (TAK)

16.66   0.02 (0.12%) 10-24 00:01
Open: 16.64 Pre. Close: 16.64
High: 16.68 Low: 16.55
Volume: 708,872 Market Cap: 52,146M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.696 - 16.776 16.776 - 16.846
Low: 16.354 - 16.448 16.448 - 16.53
Close: 16.519 - 16.665 16.665 - 16.791

Technical analysis

as of: 2020-10-23 4:49:26 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 21.09     One year: 22.19
Support: Support1: 16.52    Support2: 13.74
Resistance: Resistance1: 18.05    Resistance2: 19.00
Pivot: 17.16
Moving Average: MA(5): 16.70     MA(20): 17.36
MA(100): 18.11     MA(250): 18.36
MACD: MACD(12,26): -0.42     Signal(9): -0.36
Stochastic oscillator: %K(14,3): 10.65     %D(3): 9.71
RSI: RSI(14): 33.69
52-week: High: 20.93  Low: 12.43  Change(%): -5.3
Average Vol(K): 3-Month: 107115  10-Days: 105158

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TAK has closed above bottom band by 21.9%. Bollinger Bands are 26.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 23 Oct 2020
InvestorChannel's Covid-19 Watchlist Update for Friday, October 23, 2020, 16:30 EST - InvestorIntel

Fri, 23 Oct 2020
New Insight on China SXT Pharmaceuticals, Inc. (SXTC) - Stocks Register

Thu, 22 Oct 2020
Longwood, Atlas Venture inject $52M into cell therapy startup - Boston Business Journal

Wed, 14 Oct 2020
Hedge Funds Are Cashing Out Of Takeda Pharmaceutical Company Limited (TAK) - Insider Monkey

Thu, 08 Oct 2020
Oct 08, 2020 - Jones Collombin Investment Counsel Inc Buys Barrick Gold Corp, Takeda Pharmaceutical Co, Alibaba Group Holding, Sells Franco-Nevada Corp, Suncor Energy Inc, The Toronto-Dominion Bank -

Thu, 08 Oct 2020
Takeda 2020: The incredible growing/shrinking pharma – PharmaLive - PharmaLive

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 3,130
Shares Float (M) 3,130
% Held by Insiders
% Held by Institutions 4.23
Shares Short (K) 2,280
Shares Short P. Month (K) 2,720

Stock Financials

EPS 0.810
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 12.550
Profit Margin 3.69
Operating Margin
Return on Assets (ttm) 1.5
Return on Equity (ttm) 2.5
Qtrly Rev. Growth -5.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 1077.20
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio 20.57
PEG Ratio 0.19
Price to Book value 1.33
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend 1.630
Forward Dividend 0.840
Dividend Yield 0.10
Dividend Pay Date 2009-12-14
Ex-Dividend Date 2020-03-29
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.